10th International Congress on Autoimmunity (Autoimmunity 2016)

Leipzig, Germany
10th International Congress on Autoimmunity (Autoimmunity 2016)
Kenes International

Schedule of Presentations:

Wednesday, April 6, 2016
13:30:00 The Interplay of T-cells and B-cells in Autoimmune Disease PIERCARLO SARZI-PUTTINI
13:30:00 Introduction PIERCARLO SARZI-PUTTINI
13:30:00 For The Achievement of Optimal Effectiveness by Novel Treatment Strategy with IL-6 Signaling Targeted Therapy in RA​​ Takao Koike, Kazuhiko Yamamoto
13:30:00 Opening remarks: overview of Tocilizumab Takao Koike
13:35:00 Cumulative safety data for Tocilizumab Tatsuya Atsumi
13:35:00 T-cells, B-cells and Autoantibodies in Autoimmune Disease
14:05:00 Autoantibodies and Joint Destruction in Autoimmune Disease Georg Schett
14:35:00 Novel Therapy Strategies in the Treatment of Autoimmune Disease
15:05:00 Question and Answer Session, Wrap up and Closing PIERCARLO SARZI-PUTTINI, Georg Schett
16:00:00 Clinical, structural, and functional efficacy of Tocilizumab
16:25:00 The importance of IL-6 signaling inhibition from the translational research Tsutomu Takeuchi
16:55:00 The relationship between bone loss and inflammatory cytokine in RA Georg Schett
17:20:00 Closing remarks: future treatment​ of IL-6 signal inhibition Kazuhiko Yamamoto
Thursday, April 7, 2016
06:00:00 New Presentation
12:30:00 The trend for serological diagnosis of rheumatic diseases in China
12:30:00 Hall MP3&4
12:45:00 Q & A
12:50:00 The clinical performance of BioCLIA, a novel, automated and random-accessed Chemiluminescence immunoassay, in serological diagnosis of SLE patients and ANA screening in healthy individuals
13:15:00 Q & A
13:20:00 The development and evaluation of BioCLIA, a novel, automated and random-accessed chemiluminescence immunoanalyser for Autoantibody detection Charles Lees
13:45:00 Q & A
Friday, April 8, 2016
06:00:00 Hall MP3&4
Saturday, April 9, 2016
06:00:00 New Presentation
12:30:00 Quality and Clinical Safety of Immunoglobulin Therapies: Regulatory viewpoint​
12:30:00 Immunoglobulin therapy in autoimmune diseases: what do we expect?​
13:00:00 re all human intravenous immunoglobulin (IVIg) the same? Srini Kaveri
13:30:00 Management of ITP: are we comfortable with our knowledge?
Sunday, April 10, 2016
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.